Brief: Vigonvita Life Sciences Co Enters License Agreement With Simcere For Vv116
03/12/2025 10:20
Dec 3 (Reuters) - Vigonvita Life Sciences Co Ltd 2630.HK: ENTERS LICENSE AGREEMENT WITH SIMCERE FOR VV116 SIMCERE GRANTED EXCLUSIVE LICENSE FOR VV116 IN GREATER CHINA Further company coverage: 2630.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660